Workshop Report: The Economics of Precision Medicine

This report from a multi-stakeholder workshop on the ‘Economics of precision medicine’ addresses the issues of cost-effectiveness, as well as the need to revise how economic and social value can be valorised and financed, and to develop new business models for fundamentally personalised gene therapies with high up-front costs.


Year:
Jul 18 2018
Publisher:
EPFL IRGC
Keywords:
Note:
This publication should be cited as: EPFL IRGC (2018). The Economics of Precision Medicine. A Risk-Governance Perspective. Lausanne: EPFL International Risk Governance Center.
Laboratories:




 Record created 2018-09-05, last modified 2019-03-17

Final:
Download fulltext
PDF

Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)